{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:54:42Z","timestamp":1783119282707,"version":"3.54.6"},"posted":{"date-parts":[[2025,11,24]]},"group-title":"In Review","reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,26]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <italic>Candida auris<\/italic>\n                  is a multidrug-resistant fungal pathogen that can survive outside the host, easily spread, and colonize the healthcare environment, medical devices, and human skin.\n                  <italic>C. auris<\/italic>\n                  causes serious, life-threatening infections with mortality rates of ~\u200960% in immunosuppressed patients. Some isolates of\n                  <italic>C. auris<\/italic>\n                  are resistant to virtually all clinically available antifungal drugs. Therefore, alternative therapeutic approaches are urgently needed.\n                  <italic>C. auris<\/italic>\n                  cell wall contains \u03b2-glucan similar to non-pathogenic yeasts such as\n                  <italic>Saccharomyces cerevisiae<\/italic>\n                  . Moreover, cellular proteins are also heavily glycosylated with \u03b2-1,3 and \u03b2-1,6 glycan structures. Recently, a monoclonal antibody raised against \u03b2-glucan was shown to recognize\n                  <italic>C. albicans<\/italic>\n                  hyphal-regulated cell wall protein (Hyr1p), which has a closely related family of proteins in\n                  <italic>C auris<\/italic>\n                  . We tested \u03b2-glucan chitosan particles (GCP) as a vaccine candidate and evaluated the humoral and cellular immune responses. Interestingly, GCP induced robust IgG antibody and Th1\/Th2\/ Th17 immune responses that cross-reacted with purified\n                  <italic>C. auris<\/italic>\n                  cell wall. Anti-GCP antibodies recognized the cell walls of\n                  <italic>C. auris<\/italic>\n                  isolates from four major clades through binding to cell wall glycoproteins. Mice vaccinated with GCP were protected from disseminated\n                  <italic>C. auris<\/italic>\n                  infection compared to placebo mice (40% vs. 0% survival, p\u2009=\u2009&lt;\u20090.0001). GCP-vaccinated mice had significantly lower fungal burden than placebo in target organs (kidney, heart, and brain) and fewer fungal abscesses. The mechanism of protection appeared to require antibodies and T-cell activation. These data represent an important step forward toward developing an effective vaccine strategy against multidrug-resistant\n                  <italic>C. auris<\/italic>\n                  .\n                <\/p>","DOI":"10.21203\/rs.3.rs-7942966\/v1","type":"posted-content","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:22:44Z","timestamp":1763979764000},"source":"Crossref","is-referenced-by-count":1,"title":["\u03b2-Glucan Chitosan Particle Provides Cross-Protection Against Multi-Drug- Resistant Candida auris"],"prefix":"10.21203","author":[{"given":"Shakti","family":"Singh","sequence":"first","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Barbarino","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman G.","family":"Youssef","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustav Das","family":"Gupta","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunna","family":"Nabeela","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teclegiorgis","family":"Gebremariam","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondus","family":"Alkhazraji","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Uppuluri","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Ostroff","sequence":"additional","affiliation":[{"name":"University of Massachusetts Chan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf S.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles (UCLA) Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Tracking Candida auris. Centers for Disease Control and Prevention vol. 2018 https:\/\/www.cdc.gov\/fungal\/candida-auris\/tracking-c-auris.html (2019)."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/myc.12904","article-title":"Candida auris\u2014the growing menace to global health","volume":"62","author":"Lone SA","year":"2019","unstructured":"Lone, S. A. & Ahmad, A. Candida auris\u2014the growing menace to global health. Mycoses 62, 620\u2013637 (2019).","journal-title":"Mycoses"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000411","author":"Colombo AL","year":"2017","unstructured":"Colombo, A. L., J\u00fanior, J. N. D. A. & Guinea, J. Emerging multidrug-resistant Candida species. Current Opinion in Infectious Diseases vol. 30 528\u2013538 Preprint at https:\/\/doi.org\/10.1097\/QCO.0000000000000411 (2017)."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart SR","year":"2017","unstructured":"Lockhart, S. R. et al. Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clinical Infectious Diseases 64, 134\u2013140 (2017).","journal-title":"Clinical Infectious Diseases"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07779-6","article-title":"Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species","volume":"9","author":"Mu\u00f1oz JF","year":"2018","unstructured":"Mu\u00f1oz, J. F. et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Commun 9, (2018).","journal-title":"Nat Commun"},{"key":"ref6","author":"Chow NA","year":"2020","unstructured":"Chow, N. A. et al. Tracing the evolutionary history and global expansion of candida auris using population genomic analyses. mBio 11, (2020)."},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03540-23","article-title":"Emergence of the novel sixth Candida auris Clade VI in Bangladesh","volume":"12","author":"Khan T","year":"2024","unstructured":"Khan, T. et al. Emergence of the novel sixth Candida auris Clade VI in Bangladesh. Microbiol Spectr 12, (2024).","journal-title":"Microbiol Spectr"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00101-0","article-title":"Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study","volume":"5","author":"Suphavilai C","year":"2024","unstructured":"Suphavilai, C. et al. Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study. Lancet Microbe 5, (2024).","journal-title":"Lancet Microbe"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41591-021-01383-w","article-title":"Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility","volume":"27","author":"Proctor DM","year":"2021","unstructured":"Proctor, D. M. et al. Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility. Nat Med 27, 1401\u20131409 (2021).","journal-title":"Nat Med"},{"key":"ref10","article-title":"Screening for Candida auris Colonization | Candida auris | Fungal Diseases | CDC","author":"Centers for Disease Control and Prevention","year":"2019","unstructured":"Centers for Disease Control and Prevention. Screening for Candida auris Colonization | Candida auris | Fungal Diseases | CDC. Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/fungal\/candida-auris\/c-auris-screening.html (2019).","journal-title":"Centers for Disease Control and Prevention"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jac\/dkx034","article-title":"Candida auris candidaemia in Indian ICUs: analysis of risk factors","volume":"72","author":"Rudramurthy SM","year":"2017","unstructured":"Rudramurthy, S. M. et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. Journal of Antimicrobial Chemotherapy 72, 1794\u20131801 (2017).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.micpath.2018.09.014","article-title":"Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options","volume":"125","author":"C\u00e1ssia Orlandi","year":"2018","unstructured":"de C\u00e1ssia Orlandi Sardi, J., Silva, D. R., Soares Mendes-Giannini, M. J. & Rosalen, P. L. Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options. Microb Pathog 125, 116\u2013121 (2018).","journal-title":"Microb Pathog"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/mmy\/myz112","article-title":"Comparison of risk factors and outcomes of Candida auris candidemia with non-Candida auris candidemia: A retrospective study from Pakistan","volume":"58","author":"Sayeed MA","year":"2020","unstructured":"Sayeed, M. A., Farooqi, J., Jabeen, K. & Mahmood, S. F. Comparison of risk factors and outcomes of Candida auris candidemia with non-Candida auris candidemia: A retrospective study from Pakistan. Med Mycol 58, 721\u2013729 (2020).","journal-title":"Med Mycol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcrc.2020.01.004","article-title":"Candida auris candidaemia in an intensive care unit \u2013 Prospective observational study to evaluate epidemiology, risk factors, and outcome","volume":"57","author":"Shastri PS","year":"2020","unstructured":"Shastri, P. S. et al. Candida auris candidaemia in an intensive care unit \u2013 Prospective observational study to evaluate epidemiology, risk factors, and outcome. J Crit Care 57, 42\u201348 (2020).","journal-title":"J Crit Care"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e0293011","DOI":"10.1371\/journal.pone.0293011","article-title":"Pathobiology of Candida auris infection analyzed by multiplexed imaging and single cell analysis","volume":"19","author":"Chadwick C","year":"2024","unstructured":"Chadwick, C., De Jesus, M., Ginty, F. & Martinez, J. S. Pathobiology of Candida auris infection analyzed by multiplexed imaging and single cell analysis. PLoS One 19, e0293011 (2024).","journal-title":"PLoS One"},{"key":"ref16","article-title":"Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris","volume":"9","author":"Singh S","year":"2023","unstructured":"Singh, S. et al. Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris. J Fungi (Basel) 9, (2023).","journal-title":"J Fungi (Basel)"},{"key":"ref17","author":"Hoenigl M","year":"2022","unstructured":"Hoenigl, M. et al. COVID-19-associated fungal infections. Nature Microbiology 2022 7:8 7, 1127\u20131140 (2022)."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mmy\/myy054","article-title":"Candida auris: The recent emergence of a multidrug-resistant fungal pathogen","volume":"57","author":"Forsberg K","year":"2019","unstructured":"Forsberg, K. et al. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. Med Mycol 57, 1\u201312 (2019).","journal-title":"Med Mycol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw696","author":"Clancy CJ","year":"2017","unstructured":"Clancy, C. J. & Nguyen, M. H. Emergence of candida auris: An international call to arms. Clinical Infectious Diseases vol. 64 141\u2013143 Preprint at https:\/\/doi.org\/10.1093\/cid\/ciw696 (2017)."},{"key":"ref20","unstructured":"CDC. 2019 Antibiotic Resistance Threats Report | CDC. Center for Disease Control https:\/\/www.cdc.gov\/drugresistance\/Biggest-Threats.html%0Ahttps:\/\/www.cdc.gov\/drugresistance\/\/biggest-threats.html (2021)."},{"key":"ref21","unstructured":"WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. https:\/\/www.who.int\/publications\/i\/item\/9789240060241 (2022)."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/EC.00279-10","article-title":"Candida albicans Als3, a multifunctional adhesin and invasin","volume":"10","author":"Liu Y","year":"2011","unstructured":"Liu, Y. & Filler, S. G. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell 10, 168\u2013173 (2011).","journal-title":"Eukaryot Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/IAI.00013-13","article-title":"Investigation of the function of Candida albicans Als3 by heterologous expression in Candida glabrata","volume":"81","author":"Fu Y","year":"2013","unstructured":"Fu, Y. et al. Investigation of the function of Candida albicans Als3 by heterologous expression in Candida glabrata. Infect Immun 81, 2528\u20132535 (2013).","journal-title":"Infect Immun"},{"key":"ref24","first-page":"0543","article-title":"Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells","volume":"5","author":"Phan QT","year":"2007","unstructured":"Phan, Q. T. et al. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5, 0543\u20130557 (2007).","journal-title":"PLoS Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1086\/652407","article-title":"Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target","volume":"201","author":"Luo G","year":"2010","unstructured":"Luo, G. et al. Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. Journal of Infectious Diseases 201, 1718\u20131728 (2010).","journal-title":"Journal of Infectious Diseases"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/IAI.74.5.3039-3041.2006","article-title":"The anti-candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis","volume":"74","author":"Ibrahim AS","year":"2006","unstructured":"Ibrahim, A. S., Spellberg, B. J., Avanesian, V., Fu, Y. & Edwards, J. E. The anti-candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis. Infect Immun 74, 3039\u20133041 (2006).","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1128\/IAI.73.9.6191-6193.2005","article-title":"The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice","volume":"73","author":"Spellberg BJ","year":"2005","unstructured":"Spellberg, B. J. et al. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice. Infect Immun 73, 6191\u20136193 (2005).","journal-title":"Infect Immun"},{"key":"ref28","article-title":"Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis","volume":"6","author":"Luo G","year":"2011","unstructured":"Luo, G., Ibrahim, A. S., French, S. W., Edwards, J. E. & Fu, Y. Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis. PLoS One 6, (2011).","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3389\/fimmu.2018.01349","article-title":"Human Anti-Als3p antibodies are surrogate markers of NDV-3A vaccine efficacy against recurrent vulvovaginal candidiasis","volume":"9","author":"Uppuluri P","year":"2018","unstructured":"Uppuluri, P. et al. Human Anti-Als3p antibodies are surrogate markers of NDV-3A vaccine efficacy against recurrent vulvovaginal candidiasis. Front Immunol 9, 1349 (2018).","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial","volume":"66","author":"Edwards JE","year":"2018","unstructured":"Edwards, J. E. et al. A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases 66, 1928\u20131936 (2018).","journal-title":"Clinical Infectious Diseases"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e1007460","DOI":"10.1371\/journal.ppat.1007460","article-title":"The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection","volume":"15","author":"Singh S","year":"2019","unstructured":"Singh, S. et al. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. PLoS Pathog 15, e1007460 (2019).","journal-title":"PLoS Pathog"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2007.05872.x","author":"Latg\u00e9 JP","year":"2007","unstructured":"Latg\u00e9, J. P. The cell wall: A carbohydrate armour for the fungal cell. Molecular Microbiology vol. 66 279\u2013290 Preprint at https:\/\/doi.org\/10.1111\/j.1365-2958.2007.05872.x (2007)."},{"key":"ref33","author":"Gow NAR","year":"2022","unstructured":"Gow, N. A. R. & Lenardon, M. D. Architecture of the dynamic fungal cell wall. Nature Reviews Microbiology 2022 21:4 21, 248\u2013259 (2022)."},{"key":"ref34","author":"Mambro T","year":"2021","unstructured":"Di Mambro, T. et al. A new humanized antibody is effective against pathogenic fungi in vitro. Scientific Reports 2021 11:1 11, 1\u201317 (2021)."},{"key":"ref35","author":"Rudkin FM","year":"2018","unstructured":"Rudkin, F. M. et al. Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis. Nature Communications 2018 9:1 9, 1\u201316 (2018)."},{"key":"ref36","author":"Li SS","year":"2018","unstructured":"Li, S. S. et al. Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida. Nature Communications 2018 9:1 9, 1\u201313 (2018)."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1128\/CVI.00463-13","article-title":"Characterization and optimization of the glucan particle-based vaccine platform","volume":"20","author":"Huang H","year":"2013","unstructured":"Huang, H., Ostroff, G. R., Lee, C. K., Specht, C. A. & Levitz, S. M. Characterization and optimization of the glucan particle-based vaccine platform. Clin Vaccine Immunol 20, 1585\u20131591 (2013).","journal-title":"Clin Vaccine Immunol"},{"key":"ref38","article-title":"Glucan-chitin particles enhance Th17 response and improve protective efficacy of a multivalent antigen (rCpa1) against pulmonary Coccidioides posadasii infection","volume":"86","author":"Hung CY","year":"2018","unstructured":"Hung, C. Y. et al. Glucan-chitin particles enhance Th17 response and improve protective efficacy of a multivalent antigen (rCpa1) against pulmonary Coccidioides posadasii infection. Infect Immun 86, (2018).","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/cei.13356","article-title":"F. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens","volume":"198","author":"Abraham A","year":"2019","unstructured":"Abraham, A., Ostroff, G., Levitz, S. M. & Oyston, P. C. F. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Clin Exp Immunol 198, 143 (2019).","journal-title":"Clin Exp Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-micro-030117-020406","article-title":"The Cell Wall of the Human Fungal Pathogen Aspergillus fumigatus: Biosynthesis, Organization, Immune Response, and Virulence","volume":"71","author":"Latg\u00e9 JP","year":"2017","unstructured":"Latg\u00e9, J. P., Beauvais, A. & Chamilos, G. The Cell Wall of the Human Fungal Pathogen Aspergillus fumigatus: Biosynthesis, Organization, Immune Response, and Virulence. Annu Rev Microbiol 71, 99\u2013116 (2017).","journal-title":"Annu Rev Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1128\/EC.00194-06","article-title":"Function of Candida albicans adhesin hwp1 in biofilm formation","volume":"5","author":"Nobile CJ","year":"2006","unstructured":"Nobile, C. J., Nett, J. E., Andes, D. R. & Mitchell, A. P. Function of Candida albicans adhesin hwp1 in biofilm formation. Eukaryot Cell 5, 1604\u20131610 (2006).","journal-title":"Eukaryot Cell"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817176.CH16","article-title":"Adhesins in Opportunistic Fungal Pathogens","volume":"243-P2","author":"Zordan R","year":"2014","unstructured":"Zordan, R. & Cormack, B. Adhesins in Opportunistic Fungal Pathogens. Candida and Candidiasis 243-P2 (2014) doi:10.1128\/9781555817176.CH16.","journal-title":"Candida and Candidiasis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1128\/EC.00245-09","article-title":"Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans","volume":"8","author":"Ene IV","year":"2009","unstructured":"Ene, I. V. & Bennett, R. J. Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot Cell 8, 1909\u20131913 (2009).","journal-title":"Eukaryot Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40588-020-00143-7","article-title":"Candida auris Infection and Biofilm Formation: Going Beyond the Surface","volume":"7","author":"Horton MV","year":"2020","unstructured":"Horton, M. V. & Nett, J. E. Candida auris Infection and Biofilm Formation: Going Beyond the Surface. Curr Clin Microbiol Rep 7, 51\u201356 (2020).","journal-title":"Curr Clin Microbiol Rep"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/IDR.S116229","article-title":"Current perspective on emergence, diagnosis and drug resistance in Candida auris","volume":"10","author":"Sarma S","year":"2017","unstructured":"Sarma, S. & Upadhyay, S. Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infect Drug Resist 10, 155\u2013165 (2017).","journal-title":"Infect Drug Resist"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhin.2016.08.004","article-title":"Multidrug-resistant Candida auris: \u2018new kid on the block\u2019 in hospital-associated infections?","volume":"94","author":"Chowdhary A","year":"2016","unstructured":"Chowdhary, A., Voss, A. & Meis, J. F. Multidrug-resistant Candida auris: \u2018new kid on the block\u2019 in hospital-associated infections? J Hosp Infect 94, 209\u2013212 (2016).","journal-title":"J Hosp Infect"},{"key":"ref47","author":"Kean R","year":"2019","unstructured":"Kean, R. & Ramage, G. Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris. mSphere 4, (2019)."},{"key":"ref48","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02276-21","article-title":"Comparative Transcriptomics Reveal Possible Mechanisms of Amphotericin B Resistance in Candida auris","volume":"66","author":"Shivarathri R","year":"2022","unstructured":"Shivarathri, R. et al. Comparative Transcriptomics Reveal Possible Mechanisms of Amphotericin B Resistance in Candida auris. Antimicrob Agents Chemother 66, (2022).","journal-title":"Antimicrob Agents Chemother"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00158-19","article-title":"CD4 T Cell regulation of antibodies cross-reactive with fungal cell wall-associated carbohydrates after Pneumocystis murina infection","volume":"87","author":"Rapaka RR","year":"2019","unstructured":"Rapaka, R. R., Dai, G., Zheng, M. & Kolls, J. K. CD4 T Cell regulation of antibodies cross-reactive with fungal cell wall-associated carbohydrates after Pneumocystis murina infection. Infect Immun 87, (2019).","journal-title":"Infect Immun"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-3083.1998.00350.x","article-title":"Protective Effect of \u03b2-Glucan Against Mycobacterium bovis, BCG Infection in BALB\/c Mice","volume":"47","author":"Hetland G","year":"1998","unstructured":"Hetland, G., L\u00f8vik, M. & Wiker, H. G. Protective Effect of \u03b2-Glucan Against Mycobacterium bovis, BCG Infection in BALB\/c Mice. Scand J Immunol 47, 548\u2013553 (1998).","journal-title":"Scand J Immunol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/nri2939","author":"Romani L","year":"2011","unstructured":"Romani, L. Immunity to fungal infections. Nature Reviews Immunology vol. 11 275\u2013288 Preprint at https:\/\/doi.org\/10.1038\/nri2939 (2011)."},{"key":"ref52","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1086\/529204","article-title":"Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity","volume":"197","author":"Spellberg B","year":"2008","unstructured":"Spellberg, B. et al. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. Journal of Infectious Diseases 197, 967\u2013971 (2008).","journal-title":"Journal of Infectious Diseases"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pntd.0000183","article-title":"Panunto-Castelo, A. T Helper 1\u2013Inducing Adjuvant Protects against Experimental Paracoccidioidomycosis","volume":"2","author":"Oliveira LL","year":"2008","unstructured":"de Oliveira, L. L., Coltri, K. C., Barros Cardoso, C. R., Roque-Barreira, M. C. & Panunto-Castelo, A. T Helper 1\u2013Inducing Adjuvant Protects against Experimental Paracoccidioidomycosis. PLoS Negl Trop Dis 2, e183 (2008).","journal-title":"PLoS Negl Trop Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.chom.2020.12.002","article-title":"Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies","volume":"29","author":"Huang X","year":"2021","unstructured":"Huang, X. et al. Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies. Cell Host Microbe 29, 210\u2013221.e6 (2021).","journal-title":"Cell Host Microbe"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e1013114","DOI":"10.1371\/journal.ppat.1013114","article-title":"The Emerging Fungal Pathogen Candida auris Induces IFN\u03b3 to Colonize the Skin","volume":"21","author":"Das D","year":"2025","unstructured":"Das, D., Ganesh, S. M., Mishra, A., Netea, M. G. & Thangamani, S. The Emerging Fungal Pathogen Candida auris Induces IFN\u03b3 to Colonize the Skin. PLoS Pathog 21, e1013114 (2025).","journal-title":"PLoS Pathog"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-60327-210-0_19","article-title":"Cell Wall Fractionation for Yeast and Fungal Proteomics","volume":"425","author":"Pitarch A","year":"2008","unstructured":"Pitarch, A., Nombela, C. & Gil, C. Cell Wall Fractionation for Yeast and Fungal Proteomics. Methods Mol Biol 425, 217\u2013239 (2008).","journal-title":"Methods Mol Biol"},{"key":"ref57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007460","article-title":"The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection","volume":"15","author":"Singh S","year":"2019","unstructured":"Singh, S. et al. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. PLoS Pathog 15, (2019).","journal-title":"PLoS Pathog"},{"key":"ref58","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac492.175","article-title":"97. A Cross-kingdom Vaccine Protects against Multiple Healthcare-associated Infections","volume":"9","author":"Singh S","year":"2022","unstructured":"Singh, S. et al. 97. A Cross-kingdom Vaccine Protects against Multiple Healthcare-associated Infections. Open Forum Infect Dis 9, (2022).","journal-title":"Open Forum Infect Dis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3389\/fimmu.2018.01349","article-title":"Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis","volume":"9","author":"Uppuluri P","year":"2018","unstructured":"Uppuluri, P. et al. Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis. Front Immunol 9, 1349 (2018).","journal-title":"Front Immunol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7942966\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7942966\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:19:04Z","timestamp":1780334344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7942966\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":59,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7942966\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41541-026-01485-x","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,11,24]]},"subtype":"preprint"}}